TMFM - ETF AI Analysis
Top Page
Motley Fool Mid-Cap Growth ETF (TMFM)
Rating:68Neutral
Price Target:―
Positive Factors
Strong Leading Holding
The largest position, StoneX Group, has shown very strong gains this year, helping support the fund’s overall results.
Sector Diversification Across Growth Areas
The ETF spreads its investments across technology, health care, industrials, financials, and several other sectors, reducing reliance on any single industry.
Focused U.S. Exposure
Almost all holdings are in U.S. companies, giving investors targeted exposure to the U.S. mid-cap growth market.
Negative Factors
High Expense Ratio
The fund charges a relatively high fee, which can eat into long-term returns compared with lower-cost ETFs.
Recent Weak Overall Performance
The ETF has delivered weak results so far this year and over the past few months, which may concern investors looking for steady growth.
Several Top Holdings Are Lagging
A number of the larger positions, including Healthequity, Dexcom, Toast, Broadridge, West Pharmaceutical Services, and Brown & Brown, have shown weak performance this year, weighing on the fund.
TMFM vs. SPDR S&P 500 ETF (SPY)
AUM113.85M
RegionNorth America
Expense Ratio0.85%
Beta0.94
IssuerMotley Fool
Inception DateDec 10, 2021
Dividend Yield0.07%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume13,728
30 Day Avg. Volume11,882
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
27.16Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering31
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TMFM Summary
The Motley Fool Mid-Cap Growth ETF (TMFM) is an actively managed fund that focuses on medium‑sized U.S. companies with strong growth potential, rather than tracking a set index. It spreads money across areas like technology, health care, and industrials, holding names such as Dexcom and Toast. Someone might invest in TMFM to seek higher long-term growth than large, slower-moving companies, while still getting diversification across many mid-sized businesses. A key risk is that growth-focused mid-cap stocks can be more volatile, so the ETF’s price can rise and fall more sharply than the overall market.
How much will it cost me?The Motley Fool Mid-Cap Growth ETF (TMFM) has an expense ratio of 0.85%, meaning you’ll pay $8.50 per year for every $1,000 invested. This is higher than average because it is actively managed, relying on expert stock-picking to target mid-cap growth companies with strong potential.
What would affect this ETF?The TMFM ETF, with its focus on U.S. mid-cap growth companies, could benefit from advancements in technology and innovation, particularly as its largest sector exposure is technology. Positive economic conditions and increased consumer spending may also support growth in sectors like industrials and financials. However, rising interest rates or regulatory changes could negatively impact growth-focused companies, especially in sectors like real estate and financials, which are sensitive to such factors.
TMFM Top 10 Holdings
TMFM leans heavily into U.S. mid-cap growth, with a clear tilt toward tech and health care names that give it a modern, innovation-first feel. StoneX Group has been a powerful engine lately, helping drive the fund higher, while Datadog is sprinting ahead on strong momentum in software and AI. On the flip side, QXO and GXO Logistics have been lagging, acting like a bit of sand in the fund’s gears. Health-focused names like West Pharmaceutical and Dexcom are holding steady, keeping the overall ride relatively balanced despite a few bumps.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| StoneX Group | 8.46% | $10.22M | $8.53B | 89.92% | 58 Neutral | |
| Dexcom | 5.08% | $6.14M | $28.34B | -15.37% | 79 Outperform | |
| Guidewire | 5.05% | $6.10M | $13.78B | -25.41% | 63 Neutral | |
| Healthequity | 4.95% | $5.97M | $7.39B | -14.86% | 76 Outperform | |
| West Pharmaceutical Services | 4.49% | $5.42M | $22.05B | 48.20% | 68 Neutral | |
| GXO Logistics | 4.44% | $5.37M | $5.70B | 20.27% | 68 Neutral | |
| SBA Communications | 4.36% | $5.26M | $20.81B | -14.50% | 67 Neutral | |
| Datadog | 4.35% | $5.25M | $95.80B | 126.81% | 69 Neutral | |
| QXO Inc | 4.26% | $5.15M | $11.83B | -1.92% | 66 Neutral | |
| MongoDB | 4.24% | $5.13M | $32.05B | 105.66% | 75 Outperform |
TMFM Technical Analysis
Positive
―
Price Trends
20.83
Positive
21.54
Negative
22.97
Negative
Market Momentum
0.17
Negative
55.88
Neutral
52.54
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TMFM, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 20.91, equal to the 50-day MA of 20.83, and equal to the 200-day MA of 22.97, indicating a neutral trend. The MACD of 0.17 indicates Negative momentum. The RSI at 55.88 is Neutral, neither overbought nor oversold. The STOCH value of 52.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TMFM.
TMFM Peer Comparison
Comparison Results
Performance Comparison
TMFM
Motley Fool Mid-Cap Growth ETF
21.47
-4.87
-18.49%
AVMV
Avantis U.S. Mid Cap Value ETF
―
―
―
AVMC
Avantis U.S. Mid Cap Equity ETF
―
―
―
GLRY
Inspire Faithward Mid Cap Momentum ESG ETF
―
―
―
FRTY
Alger Mid Cap 40 ETF
―
―
―
MID.ETF
American Century Mid Cap Growth Impact ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents